88 related articles for article (PubMed ID: 8232495)
1. FDA policy on women in drug trials.
Caschetta MB; Chavkin W; McGovern T
N Engl J Med; 1993 Dec; 329(24):1815-6. PubMed ID: 8232495
[No Abstract] [Full Text] [Related]
2. New FDA policy encourages inclusion of women in clinical trials.
Clin Pharm; 1993 Oct; 12(10):712-3. PubMed ID: 8258252
[No Abstract] [Full Text] [Related]
3. Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.
Merkatz RB; Temple R; Subel S; Feiden K; Kessler DA
N Engl J Med; 1993 Jul; 329(4):292-6. PubMed ID: 8305004
[No Abstract] [Full Text] [Related]
4. FDA wants to invite women into drug trials earlier.
Watson T
Nature; 1992 Nov; 360(6402):289. PubMed ID: 1448138
[No Abstract] [Full Text] [Related]
5. FDA clarifies rules for getting experimental drugs.
Finkelstein JB
J Natl Cancer Inst; 2007 Apr; 99(8):584-5, 589. PubMed ID: 17440154
[No Abstract] [Full Text] [Related]
6. FDA scrutiny and pediatric clinical investigations.
Kadzielski MA; Gordon JH
Cost Qual; 2001 Jun; ():33-6. PubMed ID: 11482257
[No Abstract] [Full Text] [Related]
7. FDA insists on more women in drug trials.
Josefson D
BMJ; 1997 Oct; 315(7112):833. PubMed ID: 9353497
[No Abstract] [Full Text] [Related]
8. New clinical trials policy at FDA.
Vastag B
Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
[No Abstract] [Full Text] [Related]
9. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
Lovell MC
Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
[No Abstract] [Full Text] [Related]
10. Does exclusion or inclusion better protect women?
Shultz MM
J Gend Specif Med; 1998; 1(2):18-22. PubMed ID: 11281007
[No Abstract] [Full Text] [Related]
11. Ethics. Clinical trials guidelines at odds with U.S. policy.
Normile D
Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
[No Abstract] [Full Text] [Related]
12. Food and Drug Administration: 100 years of protection.
Mosocco DJ
Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
[No Abstract] [Full Text] [Related]
13. Medicare's revised clinical trial policy and clinical trial-related provisions of FDAAA: what is a sponsor to do?
Dobbins K; Scanlan K
Food Drug Law J; 2007; 62(4):695-708. PubMed ID: 18557226
[No Abstract] [Full Text] [Related]
14. Pharmacometrics at FDA: evolution and impact on decisions.
Powell JR; Gobburu JV
Clin Pharmacol Ther; 2007 Jul; 82(1):97-102. PubMed ID: 17538553
[TBL] [Abstract][Full Text] [Related]
15. The FDA Amendments Act: reauthorization of the FDA.
von Eschenbach AC
Food Drug Law J; 2008; 63(2):579-84. PubMed ID: 18561478
[No Abstract] [Full Text] [Related]
16. Should it be easier or harder to use unapproved drugs and devices?
Flannery EJ
Hastings Cent Rep; 1986 Feb; 16(1):17-23. PubMed ID: 3514546
[TBL] [Abstract][Full Text] [Related]
17. Women's health issues.
Wentz AC
Adv Intern Med; 1995; 40():1-30. PubMed ID: 7747644
[No Abstract] [Full Text] [Related]
18. Changes in FDA drug classification and priority review policy.
Crawford SY
Am J Hosp Pharm; 1992 Oct; 49(10):2383, 2386. PubMed ID: 1442812
[No Abstract] [Full Text] [Related]
19. Establishment of a public docket for medical device/radiological health policy statements and operating procedure guides--FDA. Notice.
Fed Regist; 1993 Jul; 58(142):40150-1. PubMed ID: 10127710
[TBL] [Abstract][Full Text] [Related]
20. Public have right to see data from all gene trials, says FDA.
Smaglik P
Nature; 2001 Jan; 409(6819):442. PubMed ID: 11206508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
